Use of cyclosporin a in establishing epstein-barr virus-transformed human lymphoblastoid cell lines (original) (raw)

Summary

We have investigated the potential for using cyclosporin A to increase the efficiency with which Epstein-Barr virus-transformed human lymphoblast lines can be prepared. Use of this immunosuppressive drug has permitted the development of a procedure with success rates exceeding 95% despite the processing of very large numbers of samples.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Miller, G.; Lipman, M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70: 190–194; 1973.
    Article PubMed CAS Google Scholar
  2. Gusella, J.; Wexler, N.; Conneally, M.; Naylor, S.; Anderson, M.; Tanzi, R.; Watkins, P.; Ottina, K.; Wallace, M.; Sakaguchi, A.; Young, A.; Shoulson, I.; Bonilla, E.; Martin, J. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306: 234–238; 1983.
    Article PubMed CAS Google Scholar
  3. Bird, A.; McLachlan, S.; Britton, S. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature 289: 300–301; 1981.
    Article PubMed CAS Google Scholar
  4. Leapman, S.; Filo, R.; Smith, E.; Smith, P. Differential effects of cyclopsorin A on lymphocyte subpopulations. Transplant. Proc. 13: 405–409; 1981.
    PubMed CAS Google Scholar
  5. Moss, D.; Rickinson, A.; Pope, J. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int. J. Cancer 23: 618–625; 1979.
    Article PubMed CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Genetics Unit and Neurology Service, Massachusetts General Hospital, Boston, Massachusetts
    Mary Anne Anderson & James F. Gusella
  2. Department of Genetics, Harvard Medical School, Boston, Massachusetts
    Mary Anne Anderson & James F. Gusella

Authors

  1. Mary Anne Anderson
    You can also search for this author inPubMed Google Scholar
  2. James F. Gusella
    You can also search for this author inPubMed Google Scholar

Additional information

This work was supported by National Institute of Neurological and Communicative Disorders and Stroke Grants NS16367 (Huntington's Disease Center Without Walls) and NS 20012.

Rights and permissions

About this article

Cite this article

Anderson, M.A., Gusella, J.F. Use of cyclosporin a in establishing epstein-barr virus-transformed human lymphoblastoid cell lines.In Vitro 20, 856–858 (1984). https://doi.org/10.1007/BF02619631

Download citation

Key words